About
Conferences on December 13, 2012
BIOFEST-2012(Exploit current research for harnessing the field of Life sciences)
Bright International Conferences & Events Organization invites all the Academicians, Industrialists across the world to attend "BIOFEST" (International Conference and Exhibition on Life sciences) which will be held during 12-13, December, 2012 at Asia's best Convention center Awardee-Leonia International Centre for Exhibitions & Conventions, Hyderabad, India.
2nd annual Apartment Planning and Design Summit
The 2nd Annual Apartment Planning & Design Summit is the perfect opportunity to examine the challenges associated with high density living. With more and more Australians preferring to take up apartment living, this shift in urban lifestyle has a number of implications for not only policy makers and the housing sector but also architects, developers and investors. The event will explore key topics including policy & planning, development trends & outlook, urban economics, investment & taxation and much more.
Reducing eDiscovery risk for Pharmaceutical Companies
This webinar on reducing eDiscovery risks will describe an effective strategy, that pharmaceutical companies can follow, to minimize the costs associated with litigation and eDiscovery based on records management concepts.
The implications and strategic relevance of pricing and market access reform in the US and Europe
Location:
London
/
United Kingdom
Developing an effective pricing strategy is an imperative factor in the success and overall profit of a pharmaceutical product. SMi Group’s timely masterclass provides the ideal platform to improve understanding of the current and evolving pricing strategies in the context of the evolving payer environment. The event will provide a unique opportunity to understand and analyse the effects of HTA development from a payer perspective across Europe and the US, as well as learning how to plan and develop effective and effective pricing strategies taking into account recent healthcare reforms including AMNOG in Germany, the Affordable Care Act in the US and value-based pricing in the UK.
Why you should attend
Understand the facts of healthcare reform, including AMNOG in Germany, the ...
Patient Reported Outcomes (PROs): Overview and Guidance for clinical trials and medical product labeling
This webinar on patient-reported outcomes (PRO) will discuss the conceptual framework of PRO, its reliability, validity, and sensitivity when used in clinical trials. The current guidelines released to standardize PRO usage and interpretation in clinical trials will also be discussed.
Why Should You Attend:
A patient-reported outcome (PRO) is “any report of the status of a patient’s health condition that comes directly from the patient, without interpretation of the patient’s response by a clinician or anyone else.” Use of such outcome measures has recently increased as PROs have gained greater credibility and can play an important role in drug approval.
The Informed Consent Process at the Investigator Site- Who decides if it is adequate and GCP compliant, Ethics Committee, Sponsor, or Investigator?
This webinar will discuss the role of the ethics committee, the trial sponsor and investigator in providing an adequate Informed Consent (IC). It will discuss challenges and practical limitations in ensuring your informed consent is GCP compliant.
Why Should You Attend:
The purpose of this course is to explore the divergent perspectives and practical limitations of the ethics committee, sponsor, and investigator as the basis for this continuing and troubling GCP non compliance observation. No one in the clinical research field intends to provide inadequate Informed Consent. We will discuss a case study that includes findings/observations. The GCP non-compliance challenges in this system of shared responsibility will be presented.
Computerized System Validation - A Detailed Insight
This 90-minute webinar will provide a clear understanding of the concepts of computerized system validation, and describe the steps to be taken by a project team for a well-controlled and successful computerized system validation.
Why Should You Attend:
The FDA has issued a series of regulations and guidelines to define regulatory expectations for computerized system validation. In today’s medical environment, virtually all aspects of research and manufacturing are conducted using computerized systems, yet the planning, conduct, and necessary controls for validation of these systems remains problematic for many companies and industry professionals.
The 3rd Annual National Pathology Forum
The National Pathology Forum provides a platform for the public and private sectors to come together and discuss all the latest regulatory reforms in the national pathology services. Now in its third year, the forum will explore in depth two key issues: Point-of-Care Testing (PoCT) and Genetics. Some other key topics that will be explored on the day include: Competition and profitability; Consumers and patient choice and data sharing & collaboration. This is also a great opportunity for you to converse directly with the pathology representatives of your state through ‘The state Health Roundtable.’
Financial Reporting in Government Entities
The Inaugural Forum for Financial Reporting in Government Entities will help understand the changing expectations of finance leaders in Australia’s government entities. The event will provide the latest updates on policy changes, risk management and ethical behaviour. There will also be the chance to hear and join timely discussions addressing: better financial reporting in the public sector, the latest on financial reporting fraud, information systems audit, legalities of financial reporting in the public sector and much more.
ISRMAX Rice and Grain expo
ISRMAX Rice & Grain Expo 2012 concurrent event to ISRMAX Sugar and ISRMAX Horti & Agriculture Expo, scheduled to be held from 13-15 December at IARI Ground, PUSA, New Delhi- India. The upcoming event will focus on the complete value chain i.e Post harvesting of Rice and Grain Industry and provide the industry with plethora of opportunities to connect the service providers with the end users specifically in Rice and Grain Industry.
